“No. Some things just take time.”
Monday, March 31, 2014
The California stem cell agency's $40 million award to a Stanford-Salk group for stem cell genomics research is not yet a done deal.
The award was approved more than two months ago by the agency's board. However, the proposal is now caught up in a staff review of the nitty-gritty of its details.
Agency employees, as a routine matter, go through all board-approved applications to be sure all matters are in order, ranging from commitments on matching funds to overall considerations concerning the recipient's research budget.
Sometimes changes are made as the result of the staff review. In rare cases, the recipient declines the award. (See here and here for two stories about recipient rejection of the California agency's cash.)
The California Stem Cell Report earlier today inquired about the status of the stem cell genomics award.
Kevin McCormack, senior director of public communications for the agency, said it had not cleared the staff review. Asked whether there were particular issues, McCormack replied,
The stem cell genomics round was marked by complaints about irregularities, unfairness, score manipulation and the role of its president, Alan Trounson.
In the wake of the award, which was approved on a 6-1 vote by the 29-member board, the agency initiated an examination of the grant review process in the genomics round.
Board member voting on the award was limited because of widespread conflicts of interest among the agency's governing board.Sphere: Related Content